THE SPANISH SCLERODERMA STUDY GROUP: FOCUSING ON INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Sanchez Cano, D. [1 ]
Callejas Rubio, J. L. [2 ]
Rios Fernandez, R. [2 ]
Ortego Centeno, N. [2 ]
Fonollosa, V. [3 ]
Tolosa, C. [4 ]
Rodriguez Carballeira, M. [5 ]
Simeon, C. P. [3 ]
机构：
[1] Hosp Santa Ana, Internal Med, Granada, Spain
[2] HU San Cecilio, UEAS, Granada, Spain
[3] Hosp Valle De Hebron, Internal Med, Barcelona, Spain
[4] Corp Sanitaria Univ Parc Tauli, Internal Med, Sabadell, Barcelon, Spain
[5] Hosp Univ Mutua Terrassa, Internal MeD, Terrassa, Barcelon, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4967
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0449
引用
收藏
页码：823 / 823
页数：1
相关论文
共 50 条
  • [1] Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
    Sanchez-Cano, D.
    Ortego-Centeno, N.
    Callejas, J. L.
    Fonollosa Pla, V.
    Rios-Fernandez, R.
    Tolosa-Vilella, C.
    Espinosa-Garriga, G.
    Colunga-Arguelles, D.
    Egurbide-Arberas, M. V.
    Rubio-Rivas, M.
    Freire, M.
    Rios-Blanco, J. J.
    Trapiella-Martinez, L.
    Rodriguez-Carballeira, M.
    Marin-Ballve, A.
    Pla-Salas, X.
    Simeon-Aznar, C. P.
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (03) : 363 - 374
  • [2] Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
    D. Sánchez-Cano
    N. Ortego-Centeno
    J. L. Callejas
    V. Fonollosa Plá
    R. Ríos-Fernández
    C. Tolosa-Vilella
    G. Espinosa-Garriga
    D. Colunga-Argüelles
    M. V. Egurbide-Arberas
    M. Rubio-Rivas
    M. Freire
    J. J. Ríos-Blanco
    L. Trapiella-Martínez
    M. Rodríguez-Carballeira
    A. Marín-Ballvé
    X. Pla-Salas
    C. P. Simeón-Aznar
    Rheumatology International, 2018, 38 : 363 - 374
  • [3] Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease Analysis of the Scleroderma Lung Study Placebo Group
    Khanna, Dinesh
    Tseng, Chi-Hong
    Farmani, Niloofar
    Steen, Virginia
    Furst, Daniel E.
    Clements, Philip J.
    Roth, Michael D.
    Goldin, Jonathan
    Elashoff, Robert
    Seibold, James R.
    Saggar, Rajeev
    Tashkin, Donald P.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3078 - 3085
  • [4] Interstitial lung disease: is interstitial lung disease the same as scleroderma lung disease?
    Murray, Lynne A.
    Rubinowitz, Ami
    Herzog, Erica L.
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (06) : 656 - 662
  • [5] Interstitial lung disease in scleroderma
    White, B
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) : 371 - +
  • [6] Interstitial Lung Disease in Scleroderma
    Schoenfeld, Sara R.
    Castelino, Flavia V.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (02) : 237 - +
  • [7] Cyclophosphamide for scleroderma interstitial lung disease
    Antoniu, Sabina A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 393 - 395
  • [8] Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease Findings From the Scleroderma Lung Study
    Theodore, Arthur C.
    Tseng, Chi-Hong
    Li, Ning
    Elashoff, Robert M.
    Tashkin, Donald P.
    CHEST, 2012, 142 (03) : 614 - 621
  • [9] Mycophenolate mofetil for interstitial lung disease in scleroderma
    Plastiras, S. C.
    Vlachoyiannopoulos, P. G.
    Tzelepis, G. E.
    RHEUMATOLOGY, 2006, 45 (12) : 1572 - 1572
  • [10] Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease
    Ludwicka-Bradley, Anna
    Silver, Richard M.
    Bogatkevich, Galina S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 212 - 222
12345